Category Archives Issue 365

Austin DeCoster, who owns the Iowa egg production facility at the center of a Salmonella outbreak that has sickened hundreds, reportedly testified during a U.S. House Energy and Commerce subcommittee hearing that his company “was horrified to learn that our eggs may have made people sick.” DeCoster was also quoted as saying, “We apologize to everyone who may have been sickened by eating our eggs.” With evidence apparently mounting that DeCoster operations have been flouting worker, environmental and food safety regulations for years, it is reportedly becoming clearer to legislators that food safety “is a public health imperative” that should be addressed at the federal level. DeCoster egg farms on the East Coast were reportedly responsible in the 1980s for Salmonella outbreaks that killed a number of people and sickened hundreds more, leading several states to ban the sale of his eggs. During the hearing, Democratic Representative Edward Markey (Mass.)…

Concerned about certified-organic agricultural interests in his state and consumer confidence in the “organics” label, Senator Charles Schumer (D-N.Y.) has called on Agriculture Secretary Tom Vilsack to “ensure that foreign imports, especially from China, meet the same high standards as domestically produced organic products.” In his September 20, 2010, letter, Schumer refers to media accounts questioning the validity of organic claims for Chinese agricultural exports and a U.S. Department of Agriculture (USDA) audit that revealed “potential problems with oversight of Chinese-produced organic products.” Schumer urges the agency “to review its system of oversight for foreign certifiers, especially those operating in China,” to ensure that current practices comply with U.S. standards. Schumer states, “[G]iven China’s extremely poor track record on ensuring the safety and quality of its products, it is imperative that USDA thoroughly scrutinize its program to certify Chinese organic products to determine if it is managed and funded appropriately.”…

A Food and Drug Administration (FDA) advisory panel has reportedly declined to take action or make any recommendations about the safety of genetically modified (GM) salmon at the conclusion of hearings that drew considerable media and public attention. A Massachusetts based company has been trying to bring its AquAvantage® salmon to the market for more than 10 years. If it succeeds, the fish, which reportedly grow to full size in half the time as conventional salmon, will be the first GM animal sold for human consumption. According to a news source, FDA’s Veterinary Medicine Advisory Committee indicated that it lacked sufficient safety data to make a determination and suggested that the government undertake a more rigorous analysis of potential health effects and environmental impact. Agency documents made available before the hearing reportedly indicated that FDA was prepared to conclude that no biologically relevant differences between GM salmon and conventional salmon…

12
Close